Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
β Scribed by Jessica B. Katz; Alexander J. Muller; George C. Prendergast
- Book ID
- 111248857
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 236 KB
- Volume
- 222
- Category
- Article
- ISSN
- 0105-2896
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan catabolizing enzyme that has a number of immunoregulatory effects. It is expressed at high levels in the gastrointestinal tract, particularly in the small intestine, and has been implicated in the control of intestinal inflammation. However, its prec
The priming of an appropriate anti-tumor T cell response rarely results in the rejection of established tumors. The characteristics of tumors that allow them to evade a T cell-mediated rejection are unknown for many tumors. We report on evidence that the expression of the immunosuppressive enzyme, i
Innate and adaptive immunity play important roles in immunosurveillance and tumor destruction. However, increasing evidence suggests that tumor-infiltrating immune cells may have a dual function: inhibiting or promoting tumor growth and progression. Although regulatory T (Treg) cells induce immune t
## Abstract ## Background Indoleamine 2,3βdioxygenase (IDO) is an enzyme involved in the catabolism of tryptophan and has been shown to prevent rejection of the fetus during pregnancy by inhibiting alloreactive T cells. ## Methods In this study we investigated dendritic cells (DCs) that are tran